Bio -X Diagnostics
ActiveSummary
Bio -X Diagnostics has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.6m and a net result of €56,097. Equity remains stable across the filed fiscal years (±0.9% per year). Its solvency ranks better than 76% of 6032 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
07-01
State Gazette act
Resignation: Béatrice BLANCHARD (director)Permanent representatives: Philippe HIVOREL, Julien FLORI and Hendrik VAN DAM · Director discharge · Board rule11 facts ▸
- General meeting, 28-11-2024
- Director resignation, Béatrice BLANCHARD (director)
- Director discharge, Béatrice BLANCHARD (director)
- Director in office, HOLDING MAESTRO (director)
- Director in office, FINALAB SAS (director)
- Director in office, BioChek International BV (director)
- Board composition, HOLDING MAESTRO (managing director)
- Board rule, 3
- Permanent representative, Philippe HIVOREL (representative)
- Permanent representative, Julien FLORI (permanent representative)
- Permanent representative, Hendrik VAN DAM (representative)
About the unread acts
Of the 6 Belgian State Gazette acts we know for this company, 1 has been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.